Marksans Pharma Limited

MARKSANS

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 2026321

    Quarter₹ croreYoY
    Jun 2024255+39.8%
    Sept 2024309+50.8%
    Dec 2024312+29.2%
    Mar 2025299+32.9%
    Jun 2025320+25.6%
    Sept 2025320+3.8%
    Dec 2025340+8.9%
    Mar 2026362+20.8%
    Jun 2026321+0.5%
  • ₹ crore

    Jun 202617

    Quarter₹ crore
    Jun 20248
    Sept 202431
    Dec 202423
    Mar 20258
    Jun 20252
    Sept 202558
    Dec 202516
    Mar 202627
    Jun 202617
  • ₹ crore

    Jun 2026339

    Quarter₹ crore
    Jun 2024263
    Sept 2024340
    Dec 2024334
    Mar 2025307
    Jun 2025322
    Sept 2025379
    Dec 2025356
    Mar 2026389
    Jun 2026339
  • Cost structure
  • ₹ crore

    Jun 202632

    Quarter₹ crore
    Jun 202423
    Sept 202424
    Dec 202426
    Mar 202529
    Jun 202528
    Sept 202528
    Dec 202533
    Mar 202633
    Jun 202632
  • ₹ crore

    Jun 2026248

    Quarter₹ crore
    Jun 2024220
    Sept 2024264
    Dec 2024260
    Mar 2025257
    Jun 2025258
    Sept 2025257
    Dec 2025273
    Mar 2026265
    Jun 2026248
  • Exceptional items and tax
  • ₹ crore

    Jun 202690

    Quarter₹ crore
    Jun 202442
    Sept 202476
    Dec 202475
    Mar 202550
    Jun 202564
    Sept 2025121
    Dec 202582
    Mar 2026124
    Jun 202690
  • ₹ crore

    Jun 202621

    Quarter₹ crore
    Jun 202410
    Sept 202413
    Dec 202419
    Mar 202512
    Jun 202516
    Sept 202522
    Dec 202521
    Mar 202632
    Jun 202621
  • Profit
  • ₹ crore

    Jun 202669

    Quarter₹ croreYoY
    Jun 202432-27.6%
    Sept 202463+102.0%
    Dec 202455+119.3%
    Mar 202538+13.9%
    Jun 202548+50.1%
    Sept 2025100+57.9%
    Dec 202561+9.8%
    Mar 202692+144.5%
    Jun 202669+43.7%
  • Per share
  • ₹ per share

    Jun 20261.52

    Quarter₹ per share
    Jun 20240.71
    Sept 20241.39
    Dec 20241.22
    Mar 20250.83
    Jun 20251.06
    Sept 20252.20
    Dec 20251.34
    Mar 20262.03
    Jun 20261.52
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
255309312299320320340362321
Revenue YoY+39.8%+50.8%+29.2%+32.9%+25.6%+3.8%+8.9%+20.8%+0.5%
831238258162717
263340334307322379356389339
Cost structure
232426292828333332
220264260257258257273265248
Exceptional items and tax
42767550641218212490
101319121622213221
Profit
3263553848100619269
Net profit YoY-27.6%+102.0%+119.3%+13.9%+50.1%+57.9%+9.8%+144.5%+43.7%
Per share
0.711.391.220.831.062.201.342.031.52

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.